Status:
COMPLETED
Topical Compounded Pain Creams And Pain Perception (TOPCAPP)
Lead Sponsor:
Medimix Specialty Pharmacy, LLC
Conditions:
Pain
Eligibility:
All Genders
18-65 years
Brief Summary
To evaluate the change in patient pain perception with the use of a topical compounded pain cream regimen.
Detailed Description
This is a prospective,observational,single center, open label study of patients that receive a combination topical compounded analgesic medication with no comparator group.
Eligibility Criteria
Inclusion
- Participants must be diagnosed with an ICD9 code indicative of chronic pain.
- Participants must be starting a new regimen of topical therapy with multiple compounded agents.
- Participants must be expecting to receive therapy for at least 12 weeks.
- Participants must be between 18 and 65 years of age.
- Participants must be able to provide sound written and verbal informed consent.
Exclusion
- Participants must not have prior hypersensitivity or adverse events to any of the components in the customized prescription.
- Participants must not be pregnant or breastfeeding women.
- Participants must not have a diagnosis of cancer within the past 5 years.
Key Trial Info
Start Date :
November 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
285 Patients enrolled
Trial Details
Trial ID
NCT01862848
Start Date
November 1 2012
End Date
June 1 2015
Last Update
June 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Medimix Specialty Pharmacy, LLC
Jacksonville, Florida, United States, 32216